home / stock / soly / soly news

SOLY News and Press, Soliton Inc. From 10/10/19

Stock Information
Company Name: Soliton Inc.
Stock Symbol: SOLY
Market: NYSE
Website: soliton.com
Menu
SOLY SOLY Quote SOLY Short SOLY News SOLY Articles SOLY Message Board
Get SOLY Alerts

News, Short Squeeze, Breakout and More Instantly...
SOLY - Soliton Announces $6.25 Million Private Placement

HOUSTON , Oct. 10, 2019 /PRNewswire/ -- Soliton, Inc. (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has entered into defi...
SOLY - Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023

October 8, 2019 Palm Beach, FL – October 8, 2019 – Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases – trends that expand healthcare spending. W...

SOLY - Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019

HOUSTON , Oct. 8, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced ...

SOLY - Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice

HOUSTON , Oct. 3, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today annou...
SOLY - Soliton Completes Keloid POC Clinical Trial Treatments

HOUSTON , Oct. 1, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today an...

SOLY - Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019

HOUSTON , Sept. 24, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ...

SOLY - Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars

HOUSTON , Sept. 19, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ...
SOLY - Soliton Completes Trial Enrollment and Conducts Initial Site Training to Start Keloid Trial

HOUSTON , Sept. 17, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ann...

SOLY - Soliton Announces Site Selected for Clinical Trial to Treat Fibrotic Scars

HOUSTON , Sept. 10, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ann...

SOLY - Soliton Releases Letter to Shareholders

HOUSTON , Sept. 9, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced...
Previous 10 Next 10